Bio Green Med Solution Inc (BGMS) Stock Analysis
Verdict: AVOID
Massive cash burn and 96% price collapse make the Future NRG merger a desperate survival play rather than a growth catalyst.
Investment score: 31/100
Analysis as of
Is Bio Green Med Solution Inc stock worth reviewing? The TradeMates thesis
Extreme risk micro-cap in the midst of a pivot. Financials are distressed with negative equity in 2024 and heavy FCF burn.
7-factor investment score
- Valuation: 40/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 15/100 (weight 15%)
- Earnings Quality: 35/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 20/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
Bio Green Med Solution Inc opportunities and risks
What speaks for BGMS
- Future NRG Merger Pivot
What speaks against BGMS
- Imminent Liquidity Crunch
Peers and competitors
- ALPS
- GLLI
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| BGMS | n/a | 1.5x | 0.3x | 18.4% | -204.2% | -77.8% |
| ALPS | n/a | 34.6x | n/a | 38.6% | -2004.5% | -0.8% |
| GLLI | n/a | 0.0x | n/a | 0.0% | 0.0% | -13.2% |
| Peer median | n/a | 17.3x | n/a | 19.3% | -1002.3% | -7.0% |
Frequently asked questions about Bio Green Med Solution Inc (BGMS)
Is BGMS stock a good investment?
The TradeMates model rates Bio Green Med Solution Inc as AVOID with an investment score of 31/100. Extreme risk micro-cap in the midst of a pivot. Financials are distressed with negative equity in 2024 and heavy FCF burn. This is algorithmic model output, not personal investment advice.
Is BGMS stock a buy?
The TradeMates model verdict for BGMS is AVOID with an investment score of 31/100. Treat this as a model signal to review, not a personal buy recommendation.